Symbol="ENLV"
AssetType="Common Stock"
Name="Enlivex Therapeutics Ltd"
Description="Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel."
CIK="1596812"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="37 DEREH MENACHEM BEGIN ST., 15TH FLOOR, TEL AVIV, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="48829400"
EBITDA="-25378000"
PERatio="None"
PEGRatio="None"
BookValue="2.724"
DividendPerShare="0"
DividendYield="0"
EPS="-1.7"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.22"
ReturnOnEquityTTM="-0.469"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.7"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.205"
EVToRevenue="-"
EVToEBITDA="-1.713"
Beta="0.584"
num_52WeekHigh="6.15"
num_52WeekLow="2.17"
num_50DayMovingAverage="2.601"
num_200DayMovingAverage="3.506"
SharesOutstanding="18566300"
DividendDate="2019-03-06"
ExDividendDate="None"
symbol="ENLV"
open="2.60"
high="2.74"
low="2.57"
price="2.63"
volume="13885.00"
latest_trading_day="2023-08-09"
previous_close="2.59"
change="0.04"
change_percent="1.5444%"
aroon_positive_momentum_days="5"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="5"
Volume_recent_avg="31092"
Change_recent_avg="-0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.39"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="5"
Aroon_momentum_negative="95"
image_negative_thumbnail_id_1="1151"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0184.jpeg"
image_negative_thumbnail_id_2="491"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0114.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="966"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0128.jpeg"
image_positive_thumbnail_id_2="623"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
